Wir überwinden Grenzen

Over the last years, great advances in the field have steadily improved the outcome of patients suffering from plasma cell dyscrasias. Today´s myeloma physicians, both in the clinic and outpatient office, face challenges as the options available add up to a whole variety of valuable treatment strategies, including therapies such as stem cell transplantations, novel agents and immunotherapies.